The markets closed mixed on a shortened trading day with the Dow losing 14 points to 17,798 over a disappointing start to the holiday shopping season. Nasdaq rose 11 points to 5,127.
On the upside
The Food and Drug Administration will review Repros Therapeutics' (Nasdaq: RPRX) secondary hypogonadism treatment Androxal on Monday.
Bargain hunters lifted shares of Harvard Apparatus Regenerative Technology (Nasdaq: HART).
Shares of The9 Limited (Nasdaq: NCTY) continued climbing.
On the downside
Retreating crude oil prices weighed down shares of Bonanza Creek Energy (NYSE: BCEI) and Stone Energy (NYSE: SGY).
Vale (NYSE: VALE) was removed from the BM&FBovespa's corporate sustainability index.
SouFun Holdings (NYSE: SFUN) stock fell along with a drop in Chinese stocks.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by 5 to 3 on Nasdaq. The broader S&P 500 added a point to 2,090. Bitcoin gained $8 to $355.
